Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Example Input: Most people know roughly what a bottle of vitamin D supplements might cost them, so the lack of information on cost is not a significant gap. We appreciate that the story provideddata showing the large and growing amount our society is spending on vitamin Dsupplements ($430 million in 2009), with apparently little health benefit to show for it. The story was mostly concerned with discussing the lack of benefit fromtaking extra vitamin D and calcium. And in this area it excels. While the story does lack precision when itsuggests thatadolescent girls should be getting more calcium (it neverspecifies how much they are getting now, how much more they'd need to meet the recommendations, or what benefits they might expect from this increased intake), it would be difficult for a journalist to come up with any sort of quantifiable benefit or harm estimate from the IOM report. The story captured the overall gist of the problem, which is that the evidence base is complex and still inadequate. The story notes that, contrary to the claims of many advocates for increased supplemental vitamin D, there is evidence thathigh levels of vitamin D mayhave adverseeffects, such as increased risk for fractures and an increasein the overall death rate. The story also explained that too much calcium has been linked to increased risk of kidney stones and, more tentatively, heart disease. The story did a good job of describing how the expert committee conducted its review and what evidence they found. Importantly, it noted that claims of benefit fromextra vitamin D are based onobservational studiesthat most scientists agree "cannot determine cause and effect." We also like that the story solicitedopinions froma variety of expertswith noobvious stake in the controversy. This produced a number of quotes that emphasizedthe need for restraint when interpreting the research on vitamin D. Examples: "I think thisreport will make people more cautious" and "The onus is on thepeople who propose extra calcium and vitamin D to show itis safe before they push it on people." Although we agree with the story's skeptical overall message,we think itmay haveslammed the door just a bit too hard on the possibilityof benefit from supplemental vitamin D. While claims of benefit may not be supported by the currentlyavailable evidence, they have not been conclusively disproved in randomized controlled studies, either. In fact,research isnow underway to determine whether the benefits foundin observational studies of vitamin D can be replicated in more rigorously designed trials. The story probably should have mentioned this research, and left the door to potential benefits open just a crack. No disease-mongering here. The diversity of independent voices included in this story is a real strength. Although it solicits the obligatory comment from a supplement industry spokesman, it didn't go out of its way to find any of the more widely known vitamin D experts,someof whom have been issuing recommendations that are untenable based on current evidence. The enthusiasm of some of these researchersmight beexplained bytheir significant career and financialinterests in promoting vitamin D. Notapplicable for this story. The approaches discussed are not new, and there's notreally any alternative to getting adequate amountsof these essential nutrients. The availability of vitamin D from diet, sunlight and supplements is clear from the story. The novelty of vitamin D and calcium is not really in question, so we'll call this not applicable. This story was not based on a news release.
Example Output: Report Questions Need for 2 Diet Supplements

Example Input: Since this story doesn't make claims about efficacy, costs don't seem applicable. We give this story a satisfactory score, but the story could have helped readers understand why measuring surrogate markers such as homocysteine levels can be different than tracking true outcomes such as heart attack or stroke. Here, the surrogate endpoint (homocysteine levels) "improved," but the real endpoint heart attack and stroke did not. There is no discussion of any harms associated with consumption of vitamin B supplements, although such harms would occur from vitamin B intake unlike that studied, so this gets a satisfactory grade. Two of the three studies referred to in the journal article are detailed; a brief reference is given for the third. In addition to the discussion of the studies, a quote was pulled from an editorial in the journal that published the studies. No other treatment options for lowering risk of heart attacks or strokes are mentioned. It's clear from the story that B vitamins have been in use for some time by many people for these purposes. It's clear from the story that B vitamins have been in use for some time by many people for these purposes. We can't be sure if the story relied solely or largely on a news release.
Example Output: Study: Heart attacks not cut by B vitamins

Example Input: The European Medicines Agency said in a statement that chloroquine and hydroxychloroquine two medicines embraced by U.S. President Donald Trump and others as a potential COVID-19 treatment are known to cause heart rhythm problems, especially if combined with other drugs. There is currently no licensed treatment for COVID-19 and dozens of trials are under way globally. Chloroquine and hydroxychloroquine have long been used to treat malaria and anti-inflammatory diseases like rheumatoid arthritis. In addition to the heart problems, the two drugs can also cause side effects including liver and kidney damage, seizures, and result in low blood sugar. "Clinical data are still very limited and inconclusive, and the beneficial effects of these medicines in COVID-19 have not been demonstrated," the EMA said. It noted that several clinical trials testing the drugs' effectiveness against the coronavirus are using higher than recommended doses, which it said could increase the risk of side effects including abnormal electric activity that could disrupt the heart rhythm. Earlier this month, part of a study in Brazil was suspended after doctors found one quarter of patients taking chloroquine developed irregular heart rhythms after taking a higher dose. In the U.S., doctors reported disappointing results this week for a study investigating the use of hydroxychloroquine for COVID-19. Among 368 patients who took the drug with or without the antibiotic azithromycin, there were more deaths among those who took the drug versus those who received standard care. The EMA reminded doctors and patients to report any suspected side effects from hydroxychloroquine and chloroquine to national authorities. "These must not be used without a prescription and without supervision from a doctor," the agency said. ___ Follow AP coverage of the pandemic at http://apnews.com/VirusOutbreak and https://apnews.com/UnderstandingtheOutbreak
Example Output:
EU: Malaria drugs used for virus could cause side effects.